This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Respiratory Failure, Respiratory Failure With Hypoxia or Endotracheal Intubation
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Complications are common during endotracheal intubation of critically ill adults. Manual ventilation between induction and intubation ("bag-valve-mask" ventilation) has been proposed as a means of preventing hypoxemia, the most common complication of intubation outside the operating room. Safety and efficacy data, however, are lacking. PreVent is a randomized trial comparing manual ventilation between induction and laryngoscopy to no manual ventilation between induction an laryngoscopy during endotracheal intubation of critically ill adults. The primary efficacy endpoint will be the lowest arterial oxygen saturation. The primary safety endpoints will be the lowest oxygen saturation, highest fraction of inspired oxygen, and highest positive end-expiratory pressure in the 24 hours after the procedure.

Provided treatments

  • Other: Manual Ventilation
  • Other: No Manual Ventilation

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03026322. The sponsor of the trial is Vanderbilt University Medical Center and it is looking for 401 volunteers for the current phase.
Official trial title:
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial